A day after the company trimmed 2015 guidance, Jefferies upgraded Eli Lilly (NYSE: LLY) from Hold to Buy with a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE